Management of Hazard Group 4 viral haemorrhagic fevers and similar human infectious diseases of high consequence: November 2015
Care guideline
Abstract:
This document provides guidance on the risk assessment and management
of patients in the United Kingdom in whom infection with a viral haemorrhagic
fever (VHF) should be considered or is confirmed. This guidance aims to
eliminate or minimise the risk of transmission to healthcare workers and
others coming into contact with an infected patient or their samples. This
guidance replaces the previous Advisory Committee on Dangerous
Pathogens’ (ACDP) publication ‘Management and Control of Viral
Haemorrhagic Fevers,’ published in 2012.
VHFs are severe and life-threatening viral diseases that have been reported
in parts of Africa, South America, the Middle East and Eastern Europe. VHFs
are of particular public health importance because they can spread within a
hospital setting; they have a high case-fatality rate; they are difficult to
recognise and detect rapidly; and there is no effective treatment.
Environmental conditions in the UK do not support the natural reservoirs or
vectors of any of the haemorrhagic fever viruses, and all recorded cases of
VHF in the UK have been acquired abroad, with the exception of one
laboratory worker who sustained a needle-stick injury.
In preparing this guidance, ACDP undertook a new assessment of the risks
of transmission of VHF infection. Evidence from outbreaks strongly indicates
that the main routes of transmission of VHF infection are direct contact
(through broken skin or mucous membrane) with blood or body fluids, and
indirect contact with environments contaminated with splashes or droplets of
blood or body fluids. Experts agree that there is no circumstantial or
epidemiological evidence of airborne transmission risk from VHF patients.
Following the revised risk assessment, this guidance recommends control
options for the isolation of VHF patients in the UK. These options include
flexibility in the isolation of a patient with a VHF infection within a specialist
High Level Isolation Unit (HLIU)
Category:
Management